iStent Trabecular Micro-Bypass Stent Offers Hi-Tech Solution for Glaucoma
There are few things in life more precious than vision, yet more than 60.5 million people worldwide have glaucoma, with nearly 80 million cases expected by the year 2020. Of these, 74 percent will have primary open-angle glaucoma, the second most common cause of blindness.
Preserving and enhancing vision promotes independence and leads to improved quality of life. Thanks to technological advancements, safer more effective glaucoma treatments are now available.
iStent® Trabecular Micro-Bypass Stent is a technologically advanced solution for mild-to-moderate open-angle glaucoma. The unique device can be implanted during cataract surgery, allowing both conditions to be addressed at the same time.
The FDA-approved implant is made of surgical titanium and is designed for optimal fit and secure placement. When positioned in Schlemm’s Canal, it creates a permanent opening through the blockage that has developed over time and reduces intraocular pressure by improving the eye’s natural outflow.
Results of a scientific study revealed that 68 percent of iStent patients were able to maintain their target intraocular pressure (IOP) of 21 mm HG or less, as compared to 50 percent of patients who underwent cataract surgery alone.
Tiny iStent® produces big results
Touted as the world’s tiniest implantable device, iStent is 20,000 times smaller than the intraocular lenses used in cataract surgery. Possible advantages to implantable iStent include:
- Lower IOP
- Potentially reduce or eliminate the need for costly, inconvenient glaucoma eye drops
- iStent works continuously preventing fluctuations in IOP linked to poor adherence to topical medication regimens
- Although no procedure is without risk, studies have shown iStent to be extremely safe
- Promotes early treatment of mild-to-moderate open-angle glaucoma before symptoms develop and serious damage occurs
Schedule an appointment to learn more about iStent Trabecular Micro-Bypass Stent and whether or not it is right for you.